Login
← Go Back
Ajanta Pharma
AJANTPHARM · Pharma > Pharmaceuticals & Drugs · Chairman: Mannalal B Agrawal · MD: Yogesh M Agrawal · Listing date: June 1, 2000 · Employees: 7035 · Mumbai · http://www.ajantapharma.com
Stock Price vs Company Growth
1d
3.1%
1w
6.0%
1m
5.3%
3m
7.4%
6m
3.9%
1y
14.7%
5y
24.2%
10y
11.9%
all
40.2%
🤔 How to analyze this graph?
Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price
₹ 2,729 3.1%
2,022
2,880
Company Overview
Sales
4,648 Cr
Growth: 9.7%
Profit after Tax
920 Cr
Growth: 2.5%
Large Cap
34,085 Cr
P/E: 37.2x
Industry P/E: 34.4x
Fundamentals
Sales (Cr) ₹ 4,648
Growth 9.7%
EBITDA 27.1%
P/S 7.3x
Dividend 0.9%
P/E 37.2x
Book Value ₹ 303
PEG Ratio 3.7x
ROE 23.2%
P/B 8.7x
Shareholding Pattern
Institutions
Uti Flexi Cap Fund
3.46 %
Mirae Asset Emerging Bluechip Fund
3.41 %
Sbi Magnum Global Fund
1.28 %
Llp
0.08 %
Iepf
0.06 %
Promoters
Rajesh M Agrawal, Trustee Rajesh Agrawal Trust
14.48 %
Yogesh M Agrawal, Trustee Yogesh Agrawal Trust
14.48 %
Ravi P Agrawal, Trustee Ravi Agrawal Trust
14.37 %
Aayush M Agrawal, Trustee Aayush Agrawal Trust
14.36 %
Gabs Investments Pvt Ltd
9.7 %
Others
Increase    Decrease    No change
Company Profile Detailed
Ajanta Pharma is a specialty pharmaceutical company engaged in development, manufacturing and marketing of quality finished dosages. Its business includes Branded Generics in emerging markets of Asia and Africa, Generics in the developed markets of USA and Institution sales. Emerging markets are the major contributors in company’s branded generic business where it is present across Asia and Africa.
Belongs to (28 Indices) view more
Investors (132)
sbi.magn...
motilal....
non.resi...
Followers (28)
nitin2
keerthi
deepak